| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea7da26cb077e35d67c7703ba5e49d7d |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
| filingDate |
2004-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b2ae9923701583550f705712c83db11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fc565c2782eb6b252ca4b93ace7b52c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fb5914a1acd2ce23f4bc90e12c865bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a81563e4544c17ba625d723a88e63965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66f0338e6049ce7e687f890eb59a6fbb |
| publicationDate |
2004-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-200423959-A |
| titleOfInvention |
New formulations and use thereof |
| abstract |
A tolterodine-containing pharmaceutical formulation that comprises cocoa powder, process for manufacturing the formulation and use of the formulation for treating overactive bladder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022061349-A1 |
| priorityDate |
2003-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |